Tapentadol is partially metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with drugs that enrich or repress the exercise/expression of one or more of these enzymes, in addition to with substrates of those enzymes (as a result of competition to the enzyme); some enzyme mediators/substrates demand dosing a… Read More